We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

202 hedge funds and large institutions have $1.03B invested in PDL BioPharma, Inc. in 2013 Q2 according to their latest regulatory filings, with 202 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $1.09M

Holders
202
Holders Change
+202
Holders Change %
–
% of All Funds
6.59%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
202
Increased
–
Reduced
–
Closed
–
Calls
$2.13M
Puts
$1.09M
Net Calls
+$1.04M
Net Calls Change
+$1.04M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
101
LPL Financial
California
$647K +$653K +83,808 New
SGAM
102
Smith Group Asset Management
Texas
$628K +$634K +81,327 New
PAM
103
Paradigm Asset Management
New York
$594K +$600K +77,000 New
MVP
104
Miller Value Partners
Florida
$590K +$596K +76,400 New
PA
105
Profund Advisors
Maryland
$546K +$551K +70,712 New
GIA
106
Gargoyle Investment Advisor
New Jersey
$529K +$535K +68,582 New
SC
107
Scotia Capital
Ontario, Canada
$518K +$524K +67,202 New
Tudor Investment Corp
108
Tudor Investment Corp
Connecticut
$510K +$515K +66,100 New
BC
109
Burney Company
Virginia
$504K +$510K +65,347 New
DP
110
Dearborn Partners
Illinois
$471K +$476K +61,064 New
NG
111
NatWest Group
United Kingdom
$455K +$459K +58,926 New
Grantham, Mayo, Van Otterloo & Co (GMO)
112
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$440K +$444K +56,933 New
Public Employees Retirement Association of Colorado
113
Public Employees Retirement Association of Colorado
Colorado
$440K +$444K +57,000 New
SI
114
Stephens Inc
Arkansas
$424K +$428K +54,905 New
BJ
115
BlackRock Japan
Japan
$410K +$414K +53,085 New
ISL
116
Ingalls & Snyder LLC
New York
$375K +$380K +48,700 New
WFM
117
Wilmington Funds Management
Delaware
$364K +$367K +47,106 New
MAM
118
Martingale Asset Management
Massachusetts
$361K +$364K +46,636 New
Los Angeles Capital Management
119
Los Angeles Capital Management
California
$360K +$364K +46,692 New
AG
120
Aperio Group
California
$342K +$346K +44,365 New
SB
121
Suntrust Banks
Georgia
$324K +$329K +42,132 New
UBS AM
122
UBS AM
Illinois
$321K +$324K +41,596 New
SCM
123
Sterling Capital Management
North Carolina
$316K +$320K +40,986 New
TD Asset Management
124
TD Asset Management
Ontario, Canada
$310K +$313K +40,200 New
Bank of Montreal
125
Bank of Montreal
Ontario, Canada
$300K +$303K +38,843 New
3 4
5
6 7

PDLI Hedge Fund Activity: Q2 2013 in Review

202 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q2 2013, worth a combined $1.03B.

Buyers outnumbered sellers: 202 funds opened new PDLI positions and 0 closed out — a net gain of 202 holders — while 0 added to existing stakes and 0 trimmed.

  • 202 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.03B of PDL BioPharma, Inc. stock for Q2 2013.
  • 202 funds opened new PDL BioPharma, Inc. positions in Q2 2013 and 0 closed out, a net change of +202 holders.

Based on aggregated 13F filings for Q2 2013.